Table 4.
Substance | Route of administration | Species | LD50 (mg/kg bw)a |
---|---|---|---|
Morphine | i.p. | Rat | 100 |
s.c. | Rat | 109 | |
s.c. | Rat | 630c | |
i.p. | Mouse | 140/500b | |
s.c. | Mouse | 220 | |
s.c. | Mouse | 430c | |
Codeine | i.p. | Rat | 100 |
s.c. | Rat | 229 | |
i.p. | Mouse | 60 | |
s.c. | Mouse | 84.1 | |
Thebaine | i.p. | Mouse | 20 |
s.c. | Mouse | 31 | |
Oripavine | s.c. | Rat | 13 |
i.p. | Mouse | 26.1 | |
s.c. | Mouse | 11 | |
Noscapine | i.p. | Mouse | 960 |
s.c. | Mouse | 725 | |
Papaverine | i.p. | Rat | 59.6 |
s.c. | Rat | 151 | |
i.p. | Mouse | 91 | |
s.c. | Mouse | 170 |
bw: body weight; i.p.: intraperitoneal; LD50: lethal dose for 50% of the subjects; s.c.: subcutaneous.
s.c. and i.p. LD50 values available from https://chem.nlm.nih.gov/chemidplus/ unless specified differently.
Gómez‐Serranillos et al. (1998).
Yeh (1981).